Generics: Weathering the storM

Future category M fluctuations could be limited if discussions between the British Generic Manufacturers Association (BGMA) and the Department of Health are successful. BGMA director Warwick Smith says: "Manufacturers share pharmacists' concerns about the volatility in reimbursement prices...

Full description

Saved in:
Bibliographic Details
Published inChemist & Druggist p. 26
Main Author Bremer, Steve
Format Trade Publication Article
LanguageEnglish
Published London CMP Information Ltd 05.04.2008
Subjects
Clawback
Contractors
Discounts
Drug stores
Generic drugs
Generic products
Market prices
Pharmacists
Price cuts
Profitability
Profits
Reimbursement
Wholesalers
United Kingdom > UK
Online AccessGet full text

Cover

More Information
Summary:Future category M fluctuations could be limited if discussions between the British Generic Manufacturers Association (BGMA) and the Department of Health are successful. BGMA director Warwick Smith says: "Manufacturers share pharmacists' concerns about the volatility in reimbursement prices of generics.
ISSN:0009-3033